Riverstone Holdings

Broker's Calls

CGS International upgrades Riverstone Holdings to ‘add’ as it sees better prospects in FY2025

Analyst Ong Khang Chuen increased his target price to $1.10 from 95 cents previously after Riverstone’s 3QFY2024 results.
Tianjin Pharmaceutical tops sector; Haw Par and Riverstone named as well - THE EDGE SINGAPORE

Billion Dollar Club 2024

Tianjin Pharmaceutical tops sector; Haw Par and Riverstone named as well

Despite the relatively low profile, Tianjin Pharmaceutical's improved earnings have earned recognition from investors

Results

Riverstone reports 3QFY2024 net profit of RM72.2 mil, up 21.8% y-o-y

Earnings per share stood at 4.87 sen, up from 4 sen in 3QFY2023.
Glove-maker Riverstone to benefit from recovering semiconductor sales, US-China tariffs: RHB - THE EDGE SINGAPORE

Broker's Calls

Glove-maker Riverstone to benefit from recovering semiconductor sales, US-China tariffs: RHB

That said, RHB Bank Singapore analysts have trimmed their target price on Riverstone.
Riverstone posts 54.6% increase in 1HFY2024 earnings to $144.7 mil - THE EDGE SINGAPORE

Results

Riverstone posts 54.6% increase in 1HFY2024 earnings to $144.7 mil

Riverstone Holdings recorded earnings of RM144.7 million ($42.9 million), 54.6% higher than RM93.6% in the previous year.

Broker's Calls

Growth set to accelerate, RHB maintains 'overweight' on rubber products with Riverstone as top pick

Meaningful demand recovery and pick-up in ASPs would propel glove makers' profitability in 2024.
Analysts maintain ‘buy’ call on Riverstone after 1QFY2024 results  - THE EDGE SINGAPORE

Broker's Calls

Analysts maintain ‘buy’ call on Riverstone after 1QFY2024 results

Analysts maintain ‘buy’ call on Riverstone after 1QFY2024 results

Results

Riverstone reports higher 1QFY2024 earnings on better margin mix

Riverstone plans to pay an interim dividend of 4 sen, equivalent to a payout ratio of 82.1%

Broker's Calls

RHB stays ‘overweight’ on rubber products sector with Riverstone as top pick

The analyst expects sales volumes to pick up sequentially by 2H2024, leading to an improvement in glove makers’ profitability.
Riverstone focuses on cleanrooms; Hyphens Pharma rides dual growth - THE EDGE SINGAPORE

Billion Dollar Club 2023

Riverstone focuses on cleanrooms; Hyphens Pharma rides dual growth

Riverstone cautions that the market for healthcare gloves might see consolidation in the coming years because of overcapacity.
×